Healthy Volunteers Clinical Trial
Official title:
Effects of Sleep Privation on Sensorimotor Integration of the Upper Limb During a Manual Endurance Test in Healthy Volunteers-Physiological Study
Verified date | April 2020 |
Source | Poitiers University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The investigator showed that a night of sleep deprivation halved the duration of an
inspiratory endurance test and that this loss of endurance could be secondary to a lack of
activation of the pre-motor cortex. However, the inspiratory endurance test is associated
with a feeling of dyspnea that could lead to premature arrest, and the inspiratory drive is
complex, both automatic and voluntary. The investigator can reproduce this results on a
simpler drive.
During the execution of an exercise involving repeated contractions of the hand it is
possible to record the activation of the pre-motor cortex corresponding to the phase of
preparation of the movement. The amplitude of these premotor potentials is proportional to
the developed motive force.
The purpose of this study is to assess the impact of sleep deprivation on the muscular
endurance of non-dominant in healthy subjects.
Hypothesis: Sleep deprivation causes a decrease in manual motor endurance by decreasing
cortical pre-motor control.
Main objective: To compare the motor endurance of healthy subjects after a night's sleep and
after a sleepless night.
Secondary objective: To compare the amplitude of premature cortical control at the beginning
of the endurance test after a night's sleep and after a sleepless night.
Status | Completed |
Enrollment | 21 |
Est. completion date | March 4, 2020 |
Est. primary completion date | March 4, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 25 Years to 45 Years |
Eligibility |
Inclusion Criteria: - adult male volunteers; - 25 to 45 years old - regularly sleeping more than 6 hours per night; - no excessive consumers of coffee (<3 espressos / day); - absence of muscular or neurological pathology ; - with a BMI> 18 and <25 kg / m²; - Horne and Ostberg score> 31 and <69 ; Exclusion Criteria: - female sex - history of neuromuscular disease ; - implanted metallic or electronic equipment (vascular stent, ocular implant, pacemaker ...) - history of epilepsy, or discomfort after sleep deprivation ; - poor sleepers (PSQI> 5); - exercising an activity in staggered hours; - regularly performing more than 2 nights without sleep per month; - taking drugs interfering with sleep (antidepressants, benzodiazepines ...); - having crossed 4 time zones in the previous 4 weeks. - current participation in another clinical research study; |
Country | Name | City | State |
---|---|---|---|
France | Centre Hospitalier de Poitiers | Poitiers | Vienne |
Lead Sponsor | Collaborator |
---|---|
Poitiers University Hospital |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Test duration | Time, in minutes, measured between the beginning of the endurance test and the end of the test, defined by the volunteer's inability to maintain a force of at least 30% of the maximum strength for 5 seconds. | 1 hour. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |